The syringe market is estimated to be valued at USD 24.07 Bn in 2025 and is expected to reach USD 45.46 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 9.5% from 2025 to 2032.
To learn more about this report, Download Free Sample
The syringe market is expected to witness significant growth over the forecast period. The growth of the market is anticipated to be driven by the rising prevalence of chronic diseases such as diabetes, cancer, and cardiovascular diseases. Additionally, increasing cases of needle stick injuries are compelling key players to focus on developing advanced safety syringes with retractable needles, which is further expected to provide lucrative opportunities for the market players. The growing syringe market demand for prefilled syringes for home healthcare and the advantage of administering accurate dosage is also projected to support revenue generation in the coming years.
|
Current Event |
Description and its Impact |
|
U.S. Domestic Manufacturing Expansion |
|
|
Regulatory Shifts and Quality Enforcement |
|
Uncover macros and micros vetted on 75+ parameters: Get instant access to report
The pipeline for the syringe market is evolving rapidly, with a strong focus on enhancing safety, automation, and patient-centric design. Manufacturers are actively developing next-generation syringes, such as retractable and auto-disable syringes, to minimize the risk of needlestick injuries and cross-contamination. Innovations in prefilled syringes are also gaining traction, particularly in biologics and vaccines, where precise dosing and convenience are critical. Several companies are investing in smart syringes integrated with RFID or digital tracking systems to support medication adherence and inventory management in healthcare settings. Additionally, there is increasing R&D activity aimed at producing eco-friendly and biodegradable syringe components to address growing environmental concerns. The pipeline also reflects efforts to meet the demand from home healthcare, with autoinjectors and self-administration devices in development for chronic disease management. These trends suggest a dynamic and innovation-driven future for the syringe market.
The syringe market has witnessed a steady increase in patent filings over the past decade, reflecting ongoing innovation in safety mechanisms, material science, and user-friendly designs. Patent activity has been especially strong in areas such as auto-disable syringes, retractable needle systems, and prefilled syringes, technologies aimed at enhancing patient safety and reducing contamination risks. Countries like the United States, China, and Germany lead in syringe-related patent applications, driven by their robust medical device industries and regulatory focus on infection control. Notably, several major players have secured patents for syringes designed for self-administration, a growing segment fueled by the rise in chronic diseases requiring regular injections. As demand for safer and more efficient injection devices continues, patent filings are expected to intensify, especially in smart syringe technologies integrated with digital monitoring for dosage accuracy and compliance tracking. This growing body of intellectual property indicates a competitive landscape where innovation is key to differentiation and market leadership.
In terms of usage, the disposable syringes segment is expected to hold 53.3% of the market share in 2025, owing to their convenience and ease of use. Being single-use products, disposable syringes eliminate the need for sterilization between patients, saving medical professionals significant time and effort. This makes disposable syringes particularly well-suited for administering medications and injections in busy settings like hospitals, clinics, and doctors' offices where throughput is important. By avoiding the sterilization process, disposable syringes also reduce the risk of contamination compared to reusable needles. For patients, disposable syringes assure that each injection is being administered with a new, sterile needle rather than one that may not have been adequately disinfected between uses. This is further proliferating the syringe market share.
In March 2024, Hindustan Syringes & Medical Devices (HMD) launched Dispojekt single‑use syringes featuring a one‑hand‑activated safety needle shield designed to prevent accidental needle‑stick injuries (NSIs) among healthcare professionals. These syringes, available in 22G, 23G, and 24G, integrate seamlessly into existing injection protocols without added cost.
In terms of application, the insulin syringes segment is expected to hold 36.7% of the market share in 2025 due to the large and growing diabetes patient population worldwide. Diabetes prevalence has increased dramatically in recent decades, driven by aging populations and rising rates of obesity and physical inactivity. It is estimated that over 537 million people currently have diabetes globally, and this figure is expected to continue rising substantially. As a chronic, lifelong condition, diabetes ensures a continuous long-term demand for insulin delivery. Insulin syringes provide an affordable and effective means of administering the medication. Advancements in syringe designs, like more precise dosage controls and thinner needles to reduce pain, have also enhanced the patient experience and compliance with insulin therapy.
In February 2025, JumboMed introduced a groundbreaking disposable insulin syringe with an integrated needle, designed to streamline diabetes management. The syringe offers enhanced precision, comfort, and safety, addressing key concerns for daily insulin users. Its ergonomic design and improved needle sharpness reduce injection pain and improve compliance, especially for elderly and pediatric patients. The new device also features advanced safety mechanisms to minimize needle-stick injuries. Such innovations are proliferating the syringe market share.
In terms of end users, the hospital segment is expected to hold 43.8% of the market share in 2025, owing to the scale and complexity of healthcare delivered within these settings. As institutions managing large inpatient populations as well as major outpatient services, hospitals require vast numbers of syringes on a daily basis to administer intravenous medications, oral medications via feeding tubes, injections for various procedures, and more. Even minor medical incidents or clinical tests can involve multiple syringe uses. The diversity of hospital departments, from emergency rooms treating trauma cases to specialty wards caring for long-term conditions, means syringes need to span both acute and chronic care. As healthcare grows more specialized with advancing medical technologies, hospitals also handle more complex cases than other care sites, necessitating more intensive syringe-based interventions and monitoring of drug therapies. While clinics, nursing homes, and individual physicians certainly drive syringe consumption, none match the sheer volume and variety of syringe applications in hospital environments. This makes hospitals the consistent cornerstone of the syringe market demand.
According to the National Institute of Health, a study estimates that a hospital uses about 8 syringes per patient per day, including for injections and blood draws. The World Health Organization (WHO) estimates that 16 million syringes are used globally each year.
To learn more about this report, Download Free Sample
North America remains the dominant region in the global syringe market and is anticipated to hold 39.8% of the market share in 2025. With a highly developed healthcare infrastructure and large healthcare expenditure, the region sees wide adoption of syringes across therapeutics areas. Various government initiatives to prevent needle stick injuries and spread of diseases through syringe reuse have propelled the demand for advanced syringes such as safety syringes. For example, in 2024, the U.S. Occupational Safety and Health Administration (OSHA) updated its guidelines to push for wider adoption of engineered sharps injury protection (ESIP) devices in hospitals and outpatient facilities. This move is driving demand for advanced safety syringes across the country. Apart from this, in July 2025, Health Canada approved Apotex’s Aflivu™, a biosimilar to Eylea®, offered in both pre-filled syringe and vial formats. Such innovations are proliferating the syringe market demand.
The Asia Pacific region is expected to exhibit the fastest growth in the market during forecast period due to rapid economic growth, expanding healthcare access, and increased demand for chronic disease management. Countries such as India, China, and Indonesia are witnessing a surge in demand due to rising awareness of safe injection practices and growing investment in public health infrastructure. For example, in 2024, India’s Hindustan Syringes & Medical Devices (HMD) announced a major expansion in its production capacity to meet domestic and international demand, citing a rise in vaccination programs and injectable therapies. Similarly, China’s ongoing healthcare reforms under its "Healthy China 2030" vision have boosted demand for prefilled syringes and autoinjectors, particularly in rural healthcare facilities. These developments are positioning Asia Pacific as a key contributor to global syringe supply and innovation.
In the U.S., syringe demand is rising due to a high prevalence of chronic conditions like diabetes and arthritis that require regular injections. The growing use of autoinjectors and prefilled syringes, especially for homecare, supports this trend, particularly among the aging population. Increased adoption of biologic therapies, emphasis on home-based care, and safety regulations around needlestick prevention are further driving syringe usage across hospitals and households.
India is seeing rising syringe market demand due to large-scale immunization drives, increasing diabetes cases, and growing surgical procedures. The government’s Universal Immunization Programme and expanded HPV and influenza vaccine coverage have driven bulk syringe procurement. With over 100 million diabetics, insulin syringe use is also surging. In 2024, the Indian government procured over 1 billion syringes to support national health campaigns, reflecting strong syringe market demand fueled by public health efforts and chronic disease management.
China’s demand for syringes is rising due to nationwide vaccination drives under the “Healthy China 2030” initiative and growing hospital admissions. Increased investment in rural clinics and upgraded urban hospitals has boosted syringe use for routine care, chronic disease management, and immunization. These efforts reflect China's push to enhance healthcare access and safety across all regions.
To learn more about this report, Download Free Sample
| Report Coverage | Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 24.07 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 9.5% | 2032 Value Projection: | USD 45.46 Bn |
| Geographies covered: |
|
||
| Segments covered: |
|
||
| Companies covered: |
ICU Medical, Inc., CODAN Companies, Catalent, Inc., BD, Hindustan Syringes & Medical Devices Ltd, Terumo Corporation, Schott AG, Cardinal Health, B. Braun SE, Gerresheimer AG, NIPRO, Gerresheimer AG, Dali Medical Devices, Zephyrus Innovations (Zephyrus), Stevanato Group, Xellia Pharmaceuticals, and Delta Med Group |
||
| Growth Drivers: |
|
||
| Restraints & Challenges: |
|
||
Uncover macros and micros vetted on 75+ parameters: Get instant access to report
The prevalence of chronic diseases across the world has been on a steady rise over the past few decades. Chronic diseases, such as diabetes, cardiovascular diseases, cancer, etc., have assumed epidemic proportions globally. According to the World Health Organization, chronic non-communicable diseases account for over 70% of all deaths worldwide. The rising burden of chronic illnesses can be attributed to changing lifestyle habits such as a lack of physical activity, stress, unhealthy diets rich in fat, sugar, and processed foods.
Increasing prevalence of chronic diseases such as diabetes, cancer, cardiovascular diseases, and others increases the demand for syringes and needles for diagnosis and treatment of diseases, which is expected to drive the growth of the global syringe market over the forecast period. For instance, an article published by John Wiley & Sons, Inc., a U.S.-based multinational publishing company, on January 12, 2023, stated that 1,958,310 new cancer cases and 609,820 cancer deaths are projected to occur in the U.S. in 2023. With more people being diagnosed with chronic diseases each year, the volumes of syringe utilization are expected to scale up enormously, which will drive the global syringe market growth during the forecast period.
Market players are focusing on launching technologically advanced syringes to offer customers an easy and safe administration of drugs, which is expected to fuel the global syringe market growth over the forecast period. For instance, in January 2023, Sharps Technology, Inc., an innovative medical device and drug delivery company, announced the advancement of the company's specialized prefillable syringe system product line, which will be manufactured in collaboration with Nephron Pharmaceuticals, which manufactures generic respiratory medication products, at the Inject EZ facility in West Columbia, South Carolina, U.S. Sharps' specialized product pipeline and market strategy will include a wide range of sizes, silicon-free systems that address contamination issues in the broader healthcare market, dual chamber systems that improve drug shelf life while reducing unnecessary packaging, and customized solutions for systems serving the growing autoinjector segment.
Increasing self-administration of medication is expected to offer lucrative growth opportunities for players in the global syringe market. Moreover, the advantage of self-administration is that it helps to prevent and treat symptoms and aliments without the need for a doctor. The patient experiences immediate relief. This relieves the strain on medical services in areas where they are scarce and insufficient. Key players in the market are focusing on the launch of novel self-administered prefilled syringes, which is expected to drive the market growth over the forecast period.
*Definition: The syringe market includes the manufacturing and distribution of syringes used for the injection of medications into or extraction of fluids from the human body. Syringes are a necessary medical product used by healthcare professionals, patients and caregivers for administering injections, immunizations, blood sampling, and other medical procedures. Key players in this market produce a variety of syringe types in different sizes, materials and designs to meet the needs of different medical applications, from basic disposable syringes to more advanced pre-filled syringes.
Share
Share
About Author
Manisha Vibhute is a consultant with over 5 years of experience in market research and consulting. With a strong understanding of market dynamics, Manisha assists clients in developing effective market access strategies. She helps medical device companies navigate pricing, reimbursement, and regulatory pathways to ensure successful product launches.
Missing comfort of reading report in your local language? Find your preferred language :
Transform your Strategy with Exclusive Trending Reports :
Frequently Asked Questions
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
Schedule a meeting with report Author
